Skip to main content

and
  1. Article

    Open Access

    Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers

    T-cell retargeting to eliminate CEACAM5-expressing cancer cells via CEACAM5xCD3 bispecific antibodies (BsAbs) showed limited clinical activity so far, mostly due to insufficient T-cell activation, dose-limitin...

    Anja Seckinger, Sara Majocchi, Valéry Moine in Journal of Hematology & Oncology (2023)

  2. Article

    Open Access

    A tumor microenvironment-based prognostic index for osteosarcoma

    The tumor microenvironment (TME) has a central role in the oncogenesis of osteosarcomas. The composition of the TME is essential for the interaction between tumor and immune cells. The aim of this study was to...

    Changwu Wu, Siming Gong, Yingjuan Duan, Chao Deng in Journal of Biomedical Science (2023)

  3. Article

    Open Access

    Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition

    Despite novel immunotherapies being approved and established for the treatment of non-small cell lung cancer (NSCLC), ex vivo models predicting individual patients’ responses to immunotherapies are missing. Es...

    David Junk, Sebastian Krämer, Johannes Broschewitz, Hennig Laura in Cell Death Discovery (2021)

  4. Article

    Open Access

    The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment

    Glioblastoma is the most common and aggressive brain tumour in adults with a median overall survival of only 14 months after standard therapy with radiation therapy (IR) and temozolomide (TMZ). In a novel mult...

    Ina Patties, Sonja Kallendrusch, Lisa Böhme in Journal of Experimental & Clinical Cancer … (2019)

  5. No Access

    Article

    Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model

    The non-viral delivery of small RNA molecules like siRNAs still poses a major bottleneck for their successful application in vivo. This is particularly true with regard to crossing physiological barriers upon ...

    Alexander Ewe, Sabrina Höbel, Claudia Heine in Drug Delivery and Translational Research (2017)

  6. No Access

    Article

    Organtypische Slice-Kulturen aus humanen Geweben

    Preclinical research is often realized with cell lines or animal models and implies difficulties regarding the translation into clinics because of limitations of the models, e. g. species differences. We have ...

    Felicitas Merz, Sonja Kallendrusch, Nikolas Schopow, Justus Körfer in BIOspektrum (2015)